Joshua Mondschein to Antineoplastic Agents
This is a "connection" page, showing publications Joshua Mondschein has written about Antineoplastic Agents.
Connection Strength
0.082
-
A phase I trial of concurrent sorafenib and stereotactic radiosurgery for patients with brain metastases. J Neurooncol. 2017 Jun; 133(2):435-442.
Score: 0.082
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.